Roche Holding AG 0QQ6.L Stock
Roche Holding AG Price Chart
Roche Holding AG 0QQ6.L Financial and Trading Overview
| Roche Holding AG stock price | 236.6 CHF |
| Previous Close | 298 CHF |
| Open | 300.8 CHF |
| Bid | 0 CHF x N/A |
| Ask | 0 CHF x N/A |
| Day's Range | 300.6 - 302.8 CHF |
| 52 Week Range | 267.4 - 408.8 CHF |
| Volume | 186 CHF |
| Avg. Volume | 15.74K CHF |
| Market Cap | 2.58B CHF |
| Beta (5Y Monthly) | 0.167816 |
| PE Ratio (TTM) | 0.18682471 |
| EPS (TTM) | 16.2 CHF |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
0QQ6.L Valuation Measures
| Enterprise Value | 257.35B CHF |
| Trailing P/E | 0.18682471 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.038833074 |
| Price/Book (mrq) | 8.639297 |
| Enterprise Value/Revenue | 3.874 |
| Enterprise Value/EBITDA | 10.423 |
Trading Information
Roche Holding AG Stock Price History
| Beta (5Y Monthly) | 0.167816 |
| 52-Week Change | -14.45% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 408.8 CHF |
| 52 Week Low | 267.4 CHF |
| 50-Day Moving Average | 302.76 CHF |
| 200-Day Moving Average | 340.58 CHF |
0QQ6.L Share Statistics
| Avg. Volume (3 month) | 15.74K CHF |
| Avg. Daily Volume (10-Days) | 4.27K CHF |
| Shares Outstanding | 854.16M |
| Float | 673.33M |
| Short Ratio | N/A |
| % Held by Insiders | 72.78% |
| % Held by Institutions | 8.28% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 9.5 |
| Trailing Annual Dividend Yield | 3.18% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 18.69% |
| Operating Margin (ttm) | 31.89% |
| Gross Margin | 72.00% |
| EBITDA Margin | 37.16% |
Management Effectiveness
| Return on Assets (ttm) | 14.67% |
| Return on Equity (ttm) | 44.83% |
Income Statement
| Revenue (ttm) | 66.43B CHF |
| Revenue Per Share (ttm) | 83.03 CHF |
| Quarterly Revenue Growth (yoy) | -4.50% |
| Gross Profit (ttm) | 47.83B CHF |
| EBITDA | 24.69B CHF |
| Net Income Avi to Common (ttm) | 12.42B CHF |
| Diluted EPS (ttm) | 16.197 |
| Quarterly Earnings Growth (yoy) | -36.50% |
Balance Sheet
| Total Cash (mrq) | 9.77B CHF |
| Total Cash Per Share (mrq) | 12.22 CHF |
| Total Debt (mrq) | 26.7B CHF |
| Total Debt/Equity (mrq) | 83.4 CHF |
| Current Ratio (mrq) | 1.241 |
| Book Value Per Share (mrq) | 35.026 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 18.41B CHF |
| Levered Free Cash Flow (ttm) | 11.32B CHF |
Profile of Roche Holding AG
| Country | United Kingdom |
| State | N/A |
| City | Basel |
| Address | Grenzacherstrasse 124 |
| ZIP | 4058 |
| Phone | 41 61 688 11 11 |
| Website | https://www.roche.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 103613 |
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, and internationally. The company offers pharmaceutical products in the therapeutic areas of oncology, neuroscience, infectious diseases, immunology, hemophilia, ophthalmology, dermatology, respiratory, anemia, inflammatory and autoimmune, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, cardiovascular, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. It has a research collaboration agreement with Synlogic, Inc. for the discovery of a novel synthetic biotic for the treatment of inflammatory bowel disease (IBD). Roche Holding AG was founded in 1896 and is headquartered in Basel, Switzerland.
Q&A For Roche Holding AG Stock
What is a current 0QQ6.L stock price?
Roche Holding AG 0QQ6.L stock price today per share is 236.6 CHF.
How to purchase Roche Holding AG stock?
You can buy 0QQ6.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Roche Holding AG?
The stock symbol or ticker of Roche Holding AG is 0QQ6.L.
How many shares does Roche Holding AG have in circulation?
The max supply of Roche Holding AG shares is 8.71M.
What is Roche Holding AG Price to Earnings Ratio (PE Ratio)?
Roche Holding AG PE Ratio is 0.14928690 now.
What was Roche Holding AG earnings per share over the trailing 12 months (TTM)?
Roche Holding AG EPS is 16.2 CHF over the trailing 12 months.